Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

hDcp2 Activators

hDcp2 activators are a specialized class of chemical compounds that are designed to enhance the functional activity of the human mRNA-decapping enzyme Dcp2, which is encoded by the gene NUDT16. This enzyme plays a crucial role in the regulation of mRNA degradation, a fundamental process in the post-transcriptional control of gene expression. By removing the 5' cap structure of mRNA, hDcp2 marks the transcript for degradation, thus influencing mRNA turnover and, as a result, affecting the levels of protein synthesis within the cell. The activators of hDcp2 function by stabilizing the enzyme, enhancing its affinity for the mRNA cap structure, or by facilitating the catalytic activity required for cap hydrolysis. Some compounds may mimic the natural substrates or cofactors of the enzyme, thus promoting its activity, while others could bind to allosteric sites, inducing conformational changes that lead to increased catalytic efficiency. These chemical activators are not merely indirect enhancers of general metabolic pathways but are specific to the mechanism of action of hDcp2, ensuring the precise regulation of gene expression through mRNA stability.

The biochemical activation mechanisms employed by hDcp2 activators are diverse and intricate. Certain activators may interact directly with the active site of the enzyme, promoting the decapping reaction. This can result in an accelerated turnover of mRNAs, effectively modulating gene expression patterns in response to cellular cues. Others might work by altering the interaction between hDcp2 and its coactivators or regulatory proteins, which can modulate the enzyme's activity indirectly. For instance, some molecules could disrupt inhibitory interactions, allowing hDcp2 to access its substrates more readily, or they could facilitate the formation of the hDcp2 complex with other proteins involved in mRNA decapping, such as hDcp1, enhancing the overall decapping activity. Importantly, these activators do not necessarily increase the expression of the NUDT16 gene or the abundance of the hDcp2 protein; rather, they augment the enzyme's functional activity through chemical interactions at the molecular level. This nuanced mode of action positions hDcp2 activators as tools for dissecting the complex regulatory networks that govern mRNA stability and gene expression.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin increases intracellular cAMP levels, which in turn activates PKA. PKA phosphorylation can enhance the activity of hDcp2 by promoting cellular processes that are conducive to mRNA decapping.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase, which may enhance hDcp2 activity by influencing the decapping machinery.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC). PKC has been implicated in the regulation of decapping through phosphorylation events that might enhance hDcp2 activity.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$285.00
$520.00
$1300.00
78
(4)

Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins, which could enhance hDcp2 activity by modulating proteins interacting with the decapping complex.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Rolipram inhibits phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels, which can activate PKA and subsequently might enhance hDcp2 activity via phosphorylation of associated decapping proteins.

Calyculin A

101932-71-2sc-24000
sc-24000A
sc-24000B
sc-24000C
10 µg
100 µg
500 µg
1 mg
$160.00
$750.00
$1400.00
$3000.00
59
(3)

Calyculin A is an inhibitor of PP1 and PP2A like Okadaic Acid, and it can increase phosphorylation within the cell, potentially enhancing hDcp2 activity by altering the phosphorylation status of proteins that regulate mRNA decapping.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG is a catechin found in green tea with kinase inhibitory activity. It could enhance hDcp2 function by inhibiting kinases that negatively regulate the decapping machinery.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a broad-spectrum protein kinase inhibitor; it may selectively enhance hDcp2 activity by inhibiting kinases that compete with or negatively regulate hDcp2's role in mRNA decapping.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Sphingosine-1-phosphate can activate sphingosine kinase, potentially influencing signaling pathways that converge on the mRNA decapping process, indirectly enhancing hDcp2 function.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases. This activation may indirectly enhance hDcp2 activity by affecting pathways that control mRNA stability and turnover.